ExploreWatchlistsPricing
  1. JP-listed companies
  2. Japan Tissue Engineering Co., Ltd.
  3. Financials
  4. Revenue growth (%)

Japan Tissue Engineering Co., Ltd. (7774)

Market cap
¥24.7B
P/E ratio
-45.6x
Develops and manufactures regenerative medicine products that restore tissue function by culturing patients' own cells for transplantation.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 2025-2.3-109.87%
Mar 31, 202423.7-801.18%
Mar 31, 2023-3.4-50.51%
Mar 31, 2022-6.8+202.21%
Mar 31, 2021-2.3+10.78%
Mar 31, 2020-2-153.68%
Mar 31, 20193.8-40.53%
Mar 31, 20186.4-87.02%
Mar 31, 201749.2+495.16%
Mar 31, 20168.3-73.40%
Mar 31, 201531.1-60.56%
Mar 31, 201478.8+314.46%
Mar 31, 201319

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat